Status:
UNKNOWN
Right Ventricular and Pulmonary Artery Evaluation by CMR
Lead Sponsor:
Lithuanian University of Health Sciences
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
Brief Summary
Pulmonary hypertension results in right ventricle dysfunction. Cardiac magnetic resonance derived RV ejection fraction is a prognostic value in this condition. Right ventricular geometry, function, m...
Detailed Description
Pulmonary hypertension is defined as an increase in mean pulmonary artery pressure \> 25 mmHg evaluated by right heart catheterisation. Over time increased pulmonary artery pressure eventually causes ...
Eligibility Criteria
Inclusion
- Patient with diagnosed pulmonary hypertension
- RHC, 6MWT, echocardiography, NT-pro BNP, CMR performed in one month period.
- Patients who signed study informed consent form.
Exclusion
- Coronary and valvular heart disease
- Atrial fibrillation
- Expressed shortness of breath
- Claustrophobia.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03377673
Start Date
January 1 2012
End Date
November 1 2018
Last Update
December 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LSMU
Kaunas, Lithuania, LT44307